Results
1 -
10 of
14mCPP-induced anxiety in the light-dark box in rats ? a new method for screening anxiolytic activity, Psychopharmacology Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation, Psychopharmacology Heterogeneity of Brain GABA Transporters, GABA: Receptors, Transporters and Metabolism Distribution of deramciclane (EGIS-3886) in rat brain regions, European Journal of Drug Metabolism and Pharmacokinetics Synthesis of certain 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives with anticonvulsant, hypoglycemic and anti-inflammatory potential, Journal of the Iranian Chemical Society Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration ? a positron emission tomography study, Psychopharmacology Differential EEG effects of the anxiolytic drugs, deramciclane (EGIS-3886), ritanserin and chlordiazepoxide in rats, Psychopharmacology 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze, Psychopharmacology Effect of the novel anxiolytic drug deramciclane on cytochrome Pn 450 2D6 activity as measured by desipramine pharmacokinetics, European Journal of Clinical Pharmacology Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone, European Journal of Clinical Pharmacology